Hawthorne Effect, a decentralized clinical trials platform, announced the successful closing of a $20 million Series A funding round. The new investment brought the company’s
![Hawthorne Effect Raises $20 Million for Decentralized Clinical Trials](https://mercomcapital.com/wp-content/uploads/2021/06/Hawthorne-Effect-Raises-20-Million-for-Decentralized-Clinical-Trials-1.png)
Hawthorne Effect, a decentralized clinical trials platform, announced the successful closing of a $20 million Series A funding round. The new investment brought the company’s
Florence, a remote connectivity and electronic document workflow management platform for clinical trials, closed an $80 million Series C funding round led by Insight Partners.
HealthMatch, an Australian digital clinical trial recruitment platform that matches patients with the right clinical trials, raised $18 million in a financing round led by
umotif, a London-based patient-centric data capture software platform raised £5 million (~$6.6 million) in a Series A investment round led by existing investor AlbionVC. Oslo-based
Castor, an electronic data capturing platform for the clinical trial process, raised $12 million in Series A round. Two Sigma Ventures led the funding with